IID-22 Increase the number of public health laboratories monitoring influenza virus resistance to antiviral agents
About the Data
Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Number of state public health laboratories that have submitted reports to CDC listing virus susceptibility to either class of antiviral drug (adamantanes or neuraminidase inhibitors)
Antivirals are the only prescribed medication available to treat a patient once they have contracted influenza. Monitoring for viruses resistant to antivirals is key to inform prescription and other non-pharmaceutical and pharmaceutical intervention guidance. In 2009, CDC was the only public health laboratory conducting a comprehensive monitoring of influenza A and B virus susceptibilities to four licensed anti-influenza drugs in the United States.